Literature DB >> 5316854

An eleven-year study of drug resistance in Salmonella in the Netherlands.

A Manten, P A Guinée, E H Kampelmacher, C E Voogd.   

Abstract

From 1959 to 1969 a total of 123 070 strains of salmonellae, representing nearly all the strains that have been isolated from animals and man, were collected in the Netherlands and tested for antibiotic resistance.In the course of the study, only a few strains of S. typhi and S. paratyphi B were found to be resistant to chloramphenicol, ampicillin, or tetracycline.From 1959 to 1966 there was a sharp increase in the prevalence of tetracycline resistance in both the human and the animal strains of S. typhimurium and S. panama; subsequently, however, the prevalence declined. During 1966-70 approximately one-third of the tetracycline-resistant human and animal strains of S. typhimurium were also resistant to ampicillin. This type of multiple resistance was only occasionally encountered in the other serotypes. In contrast to resistance to tetracycline and ampicillin, the incidence of S. typhimurium resistant to chloramphenicol remained low during the whole period of observation. In all other serotypes drug resistance remained at a low level.It is shown in this study that the greatly increased use of broad-spectrum antibiotics for medical and veterinary purposes and for animal feeding over the last decade in the Netherlands has not led to the development of serious drug resistance from the medical point of view. An important factor involved in the low incidence of resistance to chloramphenicol may be that R-factors in salmonellae usually lose this resistance determinant rapidly.In the Netherlands the annual mortality figures for all forms of salmonellosis decreased from 0.84 (per 100 000 inhabitants) in 1961 to 0.25 in 1969.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316854      PMCID: PMC2427895     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Treatment of typhoid fever with antibiotics.

Authors:  T E WOODWARD; J E SMADEL; R T PARKER; C L WISSEMAN
Journal:  Ann N Y Acad Sci       Date:  1952-12-30       Impact factor: 5.691

2.  Infectious drug resistance in Escherichia coli isolated from healthy farm animals.

Authors:  J R Walton
Journal:  Lancet       Date:  1966-12-10       Impact factor: 79.321

3.  [Medical aspects of infectious antibiotic resistnace in Gram-negative enteric bacterial].

Authors:  G Lebek
Journal:  Pathol Microbiol (Basel)       Date:  1967

4.  Antibiotic resistance and transfer factor in Salmonella, United States 1967.

Authors:  S A Schroeder; P M Terry; J V Bennett
Journal:  JAMA       Date:  1968-09-23       Impact factor: 56.272

5.  [Resistance to antibiotics of enterobacteria from animal material and experiments on transmission of multiple resistance in vitro].

Authors:  E Bulling; M Scholz; D S Malla
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1968-04-15       Impact factor: 0.328

6.  Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae.

Authors:  B Aserkoff; J V Bennett
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

7.  Incidence of resistance to tetracycline, chloramphenicol and ampicillin among Salmonella species isolated in The Netherlands in 1965 and 1966.

Authors:  C E Voogd; P A Guinée; A Manten; E H Kampelmacher
Journal:  Antonie Van Leeuwenhoek       Date:  1968       Impact factor: 2.271

8.  Observations on infective drug resistance in Britain.

Authors:  H W Smith; S Halls
Journal:  Br Med J       Date:  1966-01-29

9.  Ampicillin in the treatment of chronic typhoid carriers. Report on fifteen treated cases and a review of the literature.

Authors:  H J Simon; R C Miller
Journal:  N Engl J Med       Date:  1966-04-14       Impact factor: 91.245

10.  Resistance of Salmonellae isolated in 1959 and 1960 to tetracyclines and chloramphenicol.

Authors:  C H RAMSEY; P R EDWARDS
Journal:  Appl Microbiol       Date:  1961-09
View more
  8 in total

1.  Incidence of resistance to ampicillin, chloramphenicol, kanamycin and tetracycline among Salmonella species isolated in the Netherlands in 1972, 1973 and 1974.

Authors:  C E Voogd; W J van Leeuwen; P A Guinée; A Manten; J J Valkenburg
Journal:  Antonie Van Leeuwenhoek       Date:  1977       Impact factor: 2.271

2.  Decrease of drug resistance in Salmonella in the Netherlands.

Authors:  W J van Leeuwen; J van Embden; P Guinée; E H Kampelmacher; A Manten; M van Schothorst; C E Voogd
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  Drug resistance of coliform bacteria in hospital and city sewage.

Authors:  W O Grabow; O W Prozesky
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

4.  Incidence of resistance of tetracycline, chloramphenicol and ampicillin among Salmonella species isolated in the Netherlands in 1969, 1970 and 1971.

Authors:  C E Voogd; P A Guinèe; A Manten; J J Valkenburg
Journal:  Antonie Van Leeuwenhoek       Date:  1973       Impact factor: 2.271

5.  Chloramphenicol resistant Salmonella typhi: therapeutic considerations.

Authors:  J Chandra; R K Marwaha; S Sachdeva
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

Review 6.  Antibiotic usage in animals: impact on bacterial resistance and public health.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

7.  Salmonella serotypes and incidence of multiply-resistant Salmonellae isolated from diarrhoeal patients in Hong Kong from 1973-82.

Authors:  J Ling; P Y Chau; B Rowe
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 8.  Salmonella enterica Serovar Panama, an Understudied Serovar Responsible for Extraintestinal Salmonellosis Worldwide.

Authors:  Caisey V Pulford; Blanca M Perez-Sepulveda; Ella V Rodwell; François-Xavier Weill; Kate S Baker; Jay C D Hinton
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.